The combination therapy of oncolytic virotherapy
Frontiers in Pharmacology · 25.04.2024 · 15
DOI: 10.3389/fphar.2024.1380313 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Pharmacology, online erschienen am 25.04.2024. Verfasst von Yue Wang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery, Cancer Hospital of China Medical University, Liaoning Cancer Hospital & Institute, Shenyang, China. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
Compared to other cancer immunotherapies, oncolytic viruses possess several advantages, including high killing efficiency, excellent targeting capabilities, minimal adverse reactions, and multiple pathways for tumor destruction. However, the efficacy of oncolytic viruses as a monotherapy often falls short of expectations. Consequently, combining oncolytic viruses with traditional treatments to achieve synergistic effects has emerged as a promising direction for the development of oncolytic virus therapies.
Methods
This article provides a comprehensive review of the current progress in preclinical and clinical trials exploring the combination therapies involving oncolytic viruses.
Results
Specifically, we discuss the combination of oncolytic viruses with immune checkpoint inhibitors, chemotherapy, targeted therapy, and cellular therapy.
Discussion
The aim of this review is to offer valuable insights and references for the further advancement of these combination strategies in clinical applications. Further research is necessary to refine the design of combination therapies and explore novel strategies to maximize the therapeutic benefits offered by oncolytic viruses.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of General Surgery, Cancer Hospital of China Medical University, Liaoning Cancer Hospital & Institute, Shenyang, China.
- Department of Clinical Integration of Traditional Chinese and Western Medicine, Liaoning University of Traditional Chinese Medicine, Shenyang, China.
- The Second Clinical College of Dalian Medical University, Dalian, China.
- Department of Ophthalmology, First Hospital of China Medical University, Shenyang, China.
Zitieren
APA
Wang, Y., Zhu, M., Chi, H., Liu, Y., & Yu, G. (2024). The combination therapy of oncolytic virotherapy. Frontiers in Pharmacology, 15. https://doi.org/10.3389/fphar.2024.1380313
Vancouver
Wang Y, Zhu M, Chi H, Liu Y, Yu G. The combination therapy of oncolytic virotherapy. Frontiers in Pharmacology. 2024;15. doi:10.3389/fphar.2024.1380313
BibTeX
@article{Wang2024,
author = {Wang, Yue and Zhu, Mengying and Chi, Huanyu and Liu, Yang and Yu, Guilin},
title = {The combination therapy of oncolytic virotherapy},
journal = {Frontiers in Pharmacology},
year = {2024},
volume = {15},
doi = {10.3389/fphar.2024.1380313}
}
EUVIMED